2022 Program - vh2022

The committee are pleased to announce the Conference Program. Please note this is subject to change without notice.

A downloadable PDF version of the program is available here. Please be aware the program is set AEST.

Sunday 29 May Monday 30 May Tuesday 31 May

12:00pm

Registration Opens

1:00pm – 3:15pm

Session A: Opening Ceremony

Chairs: Carrie Fowlie, Hepatitis Australia & Mark Stoove, Burnet Institute, VIC

Welcome to Country

Committee Welcome

Jason Grebely, The Kirby Institute, UNSW Sydney, NSW

Community Welcome

Hepatitis C in Aboriginal & Torres Strait Islander Communities: The road to elimination by 2030

Troy Combo, Burnet Institute, QLD

The diversity of hepatitis B community: what we know is not even the tip of an iceberg

Joe Tucker, The London School of Hygiene & Tropical Medicine, UK; Danjuma Adda, World Hepatitis Alliance, Nigeria

Questions & Discussion

Hepatitis B cure: indicative findings of key informant perspectives on preparing for hepatitis B cure implementation

Jack Wallace, Burnet Institute, VIC

Hepatitis C treatment uptake following dried blood spot testing for hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot

Nigel Carrington, NSW Health, NSW

3:15pm – 4:00pm

Afternoon Tea

3:25pm – 3:50pm

Poster Tour 01

Chairs: Phoebe Schroeder, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine

Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study

Defeng Jin, Centre for Social Research in Health, UNSW, NSW

Stigma’s impact on treatment – a bilingual community health worker’s experience

Christine Olango, Bi-Lingual Community Health Worker – African, Ethnic Communities Council of Queensland

An evaluation of Hepatitis Queensland’s Community Corrections Hepatitis C clinics

Linda Selvey, School of Public Health, The University of Queensland, QLD

4:00pm – 5:40pm

Session B: Proffered Paper Session 01

Chairs: Amanda Bode, Hepatitis Australia & Phillip Read, Sexual Health and Blood Borne Viruses – SESLHD, Kirketon Road Centre, NSW

Session D: The many faces of Hepatitis B: diversity and its impact on care

Chairs: Kelly Hosking, Northern Territory Government & Menzies School of Health Research, NT & Lien Tran, WHO Collaborating Centre for Viral Hepatitis, VIC

National Prisons Hepatitis Network ‘Speed-geeking’ activity Eliminating hepatitis C in the Australian prison sector – face-to-face only

Hep@Home: Preliminary results from the evaluation of a model of care targeting people who inject drugs and providing mobile hepatitis C (HCV) testing and treatment to people who have reduced access to mainstream health services

Rosie Gilliver, Kirketon Road Centre, NSW

The patient-practitioner relationship in telehealth: Hepatitis C treatment and changing care practices during COVID-19

Renae Fomiatti , La Trobe University

Assessing national direct acting antiviral utilization for retreatment of hepatitis C due to reinfection or virological failure in Australia

Joanne Carson, The Kirby Institute, UNSW Sydney, NSW

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: a systematic review and meta-analysis

Evan Cunningham, Kirby Institute, UNSW Sydney, NSW

Tasmanian Eliminate Hepatitis C Australian Outreach Project (TEHCAO)

Megan Hughes, Sexual Health Services Tasmania, TAS

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage Study

Heather Valerio, The Kirby Insitute, UNSW Sydney, NSW

What We’ve Learnt from 7,000 Peer Work Engagements: Developing A Gold Standard for Hepatitis C Peer Partnership Work and Linkage to Care

Kyle Leadbeatter, Hepatitis NSW

Hepatitis c model of care in community corrections – reflections and opportunities to engage with a high-risk cohort

Rachel Bryett, Hepatitis Queensland, QLD

Reach-Teach-Treat model; The importance of integrating peer workers into hepatitis C models of care in community settings.

Louise Hughes and John Van Den Dungen , Hepatitis ACT

Treatment uptake for hepatitis C infection following an intervention to enhance linkage to care among people who inject drugs: the ETHOS Engage study

Anna Conway, The Kirby Insitute, UNSW Sydney, NSW

Intersectionality and hepatitis B

Chris Lemoh, Western Health, Melbourne, VIC & Victorian African Health Action Network, VIC

The implication of diversity to care and success stories: NT

Marilou Capati, Top End Medical centre, Darwin, NT

The implication of diversity to care and success stories: VIC

Nicole Allard, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, VIC

Panel Discussion

All Speakers

The National Prisons Hepatitis Network (NPHN) will be hosting a workshop during the VH2022 Conference in Brisbane. Please join us for an afternoon of the popular interactive ‘speed-geeking’ discussion activity, where you can hear from experts and participate in fast-paced, small group discussions on a variety of topics relating to hepatitis C elimination in the Australian prison sector.

5:40pm – 6:30pm

Networking Drinks

5:50pm – 6:00pm

NPHN Launch: National Consensus Statement on the Management of Hepatitis C in Australia’s Prisons

7:30am

Registration Opens

7:45am – 8:45am

NSW Health Sponsored Symposium – Eliminating Hepatitis C: A NSW Perspective

Chair: Carolyn Murray, NSW Health, NSW

Introduction

Carolyn Murray, NSW Health, NSW

Prevention and stigma & discrimination

Carla Treloar, UNSW Sydney, Centre for Social Research in Health, NSW (Virtual) & Grace Woods, Hepatitis NSW

Testing and treatment

Phillip Read, Sexual Health and Blood Borne Viruses – SESLHD, Kirketon Road Centre, NSW & Tracey Brown, Justice Health and Forensic Mental Health Network, NSW

Panel discussion

Carolyn Murray, NSW Health, NSW, Carla Treloar, UNSW Sydney, Centre for Social Research in Health, NSW (Virtual), Grace Woods, Hepatitis NSW, Phillip Read, Sexual Health and Blood Borne Viruses – SESLHD, Kirketon Road Centre, NSW & Tracey Brown, Justice Health and Forensic Mental Health Network, NSW

Closing

Carolyn Murray, NSW Health, NSW

9:00am – 11:00am

Session E: Plenary 02

Chairs: Ben Cowie, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute & Megan Hughes, Sexual Health Services Tasmania, TAS

How are we tracking against the global elimination targets for hepatitis B and C?

Carrie Fowlie, Hepatitis Australia, ACT

What policy, systems, and intervention innovations will be required to get back on track for hepatitis B and C elimination efforts?

Ed Gane, New Zealand Liver Transplant Unit, New Zealand

Questions & Discussion

Mapping the delivery of interventions for vaccine preventable infections during pregnancy in Victoria

Nafisa Yussf, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, VIC

Keep Your Foot On The Pedal! Kombi Clinic Leads HCV Re-Elimination at Lotus Glen Correctional Centre

Mim O’Flynn, Kombi Clinic, QLD

The Levinia Crooks Emerging Leader Award Presentation

11:00am – 11:30am

Morning Tea

11:30am – 1:00pm

Session F: The road to viral hepatitis elimination – where are we and where do we go from here?

Chairs: Carrie Fowlie, Hepatitis Australia & Shelley Kerr, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine

Session G: Advanced Liver Disease

Chairs: Ericka Flores, St Vincent’s Hospital Melbourne, VIC & Jessica Howell, St Vincent’s Hospital Melbourne, VIC

Introduction

Carrie Fowlie, Hepatitis Australia, ACT

National Presentation

Carrie Fowlie, Hepatitis Australia, ACT

Jurisdictional Presentation

Robert Kemp, QLD Health, QLD

Jurisdictional Presentation

Carolyn Murray, NSW Health, NSW

Jurisdictional Presentation

Elizabeth Birbilis, VIC Health, VIC

Jurisdictional Presentation

Tom Rees, SA Health, SA

Jurisdictional Presentation

Jude Bevan, WA Health WA

Jurisdictional Presentation

Fellon Gaida, Health Protection Service; Public Health, Protection and Regulation | ACT Health Directorate, ACT

Jurisdictional Presentation

Kelly Hosking, Northern Territory Government, NT

Panel Discussion

All speakers

Liver Disease 101

Zina Valaydon, Western Health, VIC

Advanced Liver Disease Models of Care

Olivia Cullen, Royal Brisbane and Women’s Hospital, QLD

Delivering Equity in HCC Care

Alan Wigg, Flinders Univeristy, SA

Compassionate care at the end of life: best practice care for people with chronic liver disease

Jennifer Philip

Questions & Discussion

1.00pm – 2.30pm

Lunch

1:30pm – 2:15pm

Sponsored Symposium – Gilead: Making a cure possible for the remaining Australians living with hepatitis C

2:30pm – 3:35pm

Session H: Proffered Paper Session 02

Chairs: Alisa Pedrana, Burnet Institute, VIC & Steven Drew, Hepatitis NSW

Session I: Proffered Paper Session 03

Chairs: Daniel O’Keefe, Burnet Institute, VIC & Katelin Haynes, Hepatitis QLD

Addressing the impact of stigma on hepatitis C treatment uptake in the elimination era

Adrian Farrugia, La Trobe University, VIC

Defeng Jin, Centre for Social Research in Health, UNSW, NSW

A Partnership Approach to enabling access to Hepatitis C treatment without visiting the Hospital in a Remote Setting

Anngie Everitt, Menzies School of Health Research, NT

Conducting a Needs and Assets Assessment for Mothers Living with Hepatitis B in South Eastern Sydney Local Health District

Tiana Parashko, SESLHD HIV & Related Programs, NSW

Aboriginal Health in Aboriginal Hands: How an Aboriginal Community Controlled Organisation is working to eliminate Hepatitis C

Daniel Hunt, Derbarl Yerrigan Health Services Aboriginal Corporation, WA

Prevalence of hepatitis C and injecting drug use among Aboriginal and Torres Strait Islander people in Australia: A systematic review and meta-analysis

Noah Cass, UNSW/The Kirby Institute, NSW

Validation of a novel point-of-care test for gut leakage in cirrhosis based on dimeric to monomeric IgA ratio: a pilot cohort study

Jessica Howell, St Vincent’s Hospital Melbourne, VIC

Understanding unsuccessful direct-acting antiviral hepatitis C treatment among people living with HIV from the international collaboration on hepatitis C elimination in HIV cohorts (InCHECH)

Brendan Harney, Burnet Institute, VIC

SEARCH: Screening Emergency Admissions at Risk of Chronic Hepatitis C to diagnose or “re-diagnose” infections is effective

Miriam Levy, Liverpool Hospital and UNSW, NSW

Stable rates of cirrhosis diagnosed by Fibroscan despite changing trends in liver disease epidemiology with decreased viral hepatitis: a single centre retrospective cohort study

Joan Ericka Flores, St Vincent’s Hospital Melbourne, VIC

Financial incentives to increase hepatitis C testing and treatment uptake and adherence among people at risk of or diagnosed with hepatitis C: a systematic review

Claudia Shen, Burnet Institute, VIC

3:35pm – 4:15pm

Afternoon Tea

3:40pm – 4:05pm

Poster Tour 02

Chair: Janice Pritchard – Jones, Sydney Local Health District, NSW

Access, Care and Empowerment (ACE) mobile app for people who inject drugs in Western Australia

Judith Bevan, Department of Health, WA

Trends in decompensated cirrhosis and hepatocellular carcinoma diagnosis among people with a hepatitis B notification in New South Wales: a population-based data linkage study

Syed Hassan Bin Usman Shah, The Kirby Institute, UNSW Sydney, NSW

Performance of an Ultra-sensitive HBsAg Assay

Kathy Jackson, VIDRL, VIC

Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander people with HCV infection: analysis of a national real-world cohort (REACH-C)

Jessica Buhagiar,UNSW/The Kirby Institute, NSW

A novel testing modality to address barriers to hepatitis c testing and treatment among Aboriginal and Torres Strait Islander people in New South Wales, Australia: The NSW DBS pilot study

Nigel Carrington, NSW Ministry Of Health, NSW

4:15pm – 5:45pm

Session J: Peer workers on challenging and addressing stigma in practice

Chairs: Jack Wallace, Burnet Institute, VIC & John Didlick, Hepatitis Australia & John Didlick, Hepatitis Australia, ACT

Session K: Models of Care in Different Settings

Chairs: Joss O’Loan, Kombi clinic / Inala Institute of Medical Research, QLG & Paula Binks, Menzies School of Health Research, NT

Introduction

Jack Wallace, Burnet Institute, VIC & John Didlick, Hepatitis Australia

A very, very brief introduction to stigma

Carla Treloar, Centre for Social Research in Health, UNSW Sydney, NSW

How to thrive not just survive: Peers in the workplace

Nadia Gavin, FUSE Initiatives

Panel Discussion & Audience Q&A

Esha Leyden, Quihn, QLD; Niki Parry, Quihn; Kiah Glasson, Hepatitis NSW & George Gurruwiwi, Menzies, NT; Melita McKinnon, Menzies School of Health Research, NT; Nadia Gavin, Harm Reduction Victoria; Bindi Andrews, Hepatitis NSW; Will Smith, Hepatitis NSW (Virtual) and Sophie Osborne, Quihn, QLD (Virtual)

Improving Hepatitis C Care in Mental Health Settings

Meghan Macdonald, Hunter New England Population Health, NSW

Prisons

Dorrit Grimstrup, QUIHN, QLD

Homelessness as a specific target population group

Kim Raynor, Micah Projects, QLD

Getting back on track towards elimination – pandemic proof models of care

Jane Davies, Menzies School of Health Research, NT

Questions & Discussion

7:00pm – 11:00pm

Conference Dinner

8.30am

Registration Opens

9.00am – 10.45am

Session L: Plenary 03

Chairs: Bianca Prain, NSW Ministry of Health & Nick Scott, Burnet Institute, VIC

Implementation Science: What are we talking about and how can apply it to improve our approaches for hepatitis B and C infections

Jeremy Grimshaw, Ottawa Hospital Research Institute and University of Ottawa, Canada

Engaging those who are undiagnosed or lost to care

Melinda Hassall, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, QLD

Questions & Discussion

Are we leaving women who inject drugs behind on the ‘road to hepatitis C elimination’? A qualitative exploration to minimise inequalities in health

Alison Marshall, The Kirby Institute, UNSW Sydney, NSW

The cascade of care for women with CHB during pregnancy: progress, gaps and opportunities

Jennifer MacLachlan, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, VIC

10.45am – 11.30am

Morning Tea

10:55am – 11:15am

Poster Tour 03

Chair: Sinead Sheils, Australasian Hepatology Association, NSW

Clinical characteristics of sex workers and men who have sex with men, living with CHB, attending a publicly funded sexual health service

Anik Ray, Sydney Sexual Health Centre, NSW

Love your liver with good nutrition

Tracey Jones, Justice Health and Forensic Mental Health Network, NSW

Describing client presentations at four syringe dispensing machines in South-East Melbourne, Australia

Phoebe Kerr, Burnet Institute, VIC

Coordinated Hepatitis responses to Enhance the Cascade of Care by optimising Existing Surveillance Systems (CHECCS) in Victoria

Mielle Abbott, Who Collaborating Centre for Viral Hepatitis at The Doherty Institute, VIC

11:30am – 1:00pm

Session M: Evolving technologies and viral hepatitis care

Chairs: Joseph Doyle, Burnet Institute, VIC & Rosie Gilliver, Kirketon Road Centre, NSW

Session N: Tales from the Top End

Chair: Edan Campbell-O’Brien, NACCHO, ACT

Hepatitis B: Evaluation of current and new diagnostic biomarkers

Kathy Jackson, Victorian Infectious Diseases Reference Laboratory, VIC

Advances in HCV diagnostics

Jordan Feld, Toronto Centre for Liver Disease, Toronto General Hospital, Canada

Advances in diagnostic testing for liver disease and HCC

Jessica Howell, St. Vincent’s Hospital Melbourne, VIC

Imagining the unimaginable: What could the future hold for new technologies and viral hepatitis care?

Mark Stoove, Burnet Institute, VIC

Questions and Discussion

Hep B PAST and Story App

Paula Binks, Menzies School of Health Research; George Gurruwiwi, Shiraline Wurrawilya and Shiraline Wurrawilya, Top End Health Service

Tales from the Top End Discussion

Paula Binks, Menzies School of Health Research; George Gurruwiwi, Menzies School of Health Research; Teresa De Santis, NT Health; Kelly Hosking, Northern Territory Government & Menzies School of Health Research; Edan Campbell-O’Brien, NACCHO, ACT; and Shiraline Wurrawilya, Top End Health Service

Q&A

Kelly Hosking, Northern Territory Government & Menzies School of Health Research and Paula Binks, Menzies School of Health Research

Quick Hep C chat with Troy Combo and wrap-up

Edan Campbell-O’Brien, NACCHO, ACT

1:00pm – 2:30pm

Lunch

1:20pm – 1:43pm

Session O: Multimedia Session

Chair: Mim O’Flynn, Kombi Clinic, QLD & Peter Sidaway, Northern Territory Aids & Hepatitis Council

ILBIJERRI Theatre Company’s VIRAL: Are You The Cure?

The LiverWELL app. An innovative approach to providing tools and information for managing liver health

Paulette Trevena, Liverwell, VIC

Hepatitis Treatment in Custody Video. Highlighting patient experiences of receiving treatment whilst in custody

Tracey Brown, Justice Health and Forensic Mental Health Network, NSW

B Stronger Digital Advertising Campaign

Jessie Badger, Hepatitis Queensland, QLD

Using Social Media to Raise Awareness of Viral Hepatitis During a Pandemic

Grace Crowley, Hepatitis NSW

Session details to be confirmed

1:45pm – 2:20pm

VitalvoicesofhepC.org – Personal stories of treatment for hepatitis C – New website launch

Chair: Suzanne Fraser, Australian Research Centre in Sex, Health and Society, La Trobe University

Introduction to VitalvoicesonhepC.org, a new website on personal experiences of hepatitis C, treatment and cure

Prof Suzanne Fraser

Message from Vital voices advocate

Bernie Hobbs

Description of research project that produced Vital voices

Dr Renae Fomiatti

Overview of Vital voices

Dr Adrian Farrugia

Vital voices: consumer perspectives

Sione Crawford

Vital voices: practitioner perspectives

Dr Hester Wilson

2:30pm – 3:30pm

Session P: Proffered Paper Session 04

Chairs: Behzad Hajarizadeh, The Kirby Institute, UNSW Sydney, NSW & Nicole Allard, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, VIC

Session Q: Proffered Paper Session 05

Chairs: Thomas Wright, Justice Health and Forensic Mental Health Network, NSW & Alison Marshall, The Kirby Institute, UNSW Sydney, NSW

Improving the cascade of care for people living with Chronic Hepatitis B in the Central Australia Health Service Primary Health Clinics

Kelly Banz, Central Australia Primary and Public Health Service, NT

Cost-effectiveness of microarray patches for hepatitis B virus birth-dose vaccination in low- and middle-income countries

Chris Seaman, Burnet Institute, VIC

Variations in delivery of chronic hepatitis b care to different priority ethnicities: gaps in our national response

Lien Tran, WHO Collaborating Centre for Viral Hepatitis, VIC

Culturally Responsive Care and Hepatitis B: Developing a culturally safe educational course for clinicians

Isabell Purcell, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW

Hepatitis B transmission in early life in very remote Aboriginal communities in northern Australia

Richard Sullivan, Menzies School Of Health Research, NT

B Stronger Grants Program – Meaningful engagement with Aboriginal communities through a community-led grants program

Lana Richardson, Hepatitis Queensland, QLD

Learnings from a community outreach nurse-Improving engagement and HCV care coordination for a hard-to-reach cohort in community corrections

Jeanette Tibbs, Hepatitis Queensland, QLD

The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade

Lise Laferty, Centre for Social Research in Health, UNSW Sydney, NSW

HEP CURED: A Co-designed Health Promotion Partnership Program and Strategic Messaging Campaign To Increase Hepatitis C Treatment Access For People Who Inject Drugs

Maria McMahon, Hepatitis NSW

QuIHN Hepatitis C Treatment and Management Program

Esha Leyden, QUIHN, QLD

Filling gaps for patients diagnosed with chronic hepatitis B from a Chinese speaking background

Nellie He, Ethnic Communities Council of Queensland, QLD

Culturally appropriate education model for people living with hepatitis B or C from the Vietnamese community in Queensland

Tam Do, Ethnic Communities Council of Queensland, QLD

3:35 pm – 4:00pm

Afternoon Tea

4:00pm – 5:00pm

Session R: Closing Plenary

Chairs: Jason Grebely, The Kirby Institute, UNSW Sydney, NSW & Kelly Hosking, Northern Territory Government & Menzies School of Health Research, NT

Connecting with Care & Panel Discussion

Introduction

Jason Grebely, International Network on Health and Hepatitis in Substance Users

Film Launch

Panel Discussion

Chair: Jason Grebely

Panellists: Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, NSW; Charles Henderson, NSW Users and AIDS Association (NUAA), NSW; Marianne Jauncey, Uniting Sydney Medically Supervised Injecting Centre – Sydney MSIC, NSW (Virtual); Will Wood, Uniting Sydney Medically Supervised Injecting Centre – Sydney MSIC, NSW (Virtual)

Committee Closing Remarks

Kelly Hosking, Northern Territory Government & Menzies School of Health Research, NT

ASHM Closing Remarks

Alexis Apostolellis, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, NSW